System Biology Approach for Identification of New Targets and Biomarkers: I-Ming Wang, PhD | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« The Role of Informatics in ADMA Pharmacogenetics: Boyd Steere, PhD

BIND Therapeutics and AstraZeneca: Collaboration on Nanomedicines Selectively of Drug Concentrations – Tumor vs Healthy Tissues »

System Biology Approach for Identification of New Targets and Biomarkers: I-Ming Wang, PhD

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

I-Ming Wang, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/Wang_I-Ming.pdf

Posted in Biomarkers & Medical Diagnostics, Computational Biology/Systems and Bioinformatics | 1 Comment

One Response

on April 22, 2013 at 5:01 PM | Reply larryhbern

I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 2,000 other subscribers
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: